ArticleCancer causes & control : CCC2026
Tissue levels of persistent organic pollutants and biotransformation enzyme polymorphisms in human stomach cancer.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposePersistent organic pollutants (POPs) are lipophilic environmental contaminants with carcinogenic potential, yet data on their accumulation in human gastric tissue are limited. This study aimed to comprehensively quantify 32 POPs in malignant and non-malignant gastric tissues and to evaluate their distribution across blood and omental adipose tissue, together with metabolic enzyme activity, genetic polymorphisms, and oxidative damage markers.
methodsPOP concentrations were measured in gastric tissue, blood, and omental adipose tissue from stomach cancer patients and controls undergoing stomach reduction surgery. Associations were evaluated using multivariable models adjusted for age, sex, and smoking. False discovery rate (FDR) correction was applied to account for multiple testing. Genotyping of CYP1A1, GSTP1, GSTM1, GSTT1, and OGG1 was performed, and CYP1A1 enzyme activity and urinary oxidative damage biomarkers were assessed.
resultsThe most robust differences were observed in gastric tissue, where 13 individual POPs and selected chemical classes remained significantly different between cancer and control groups after FDR correction. In blood, five individual POPs remained significant after correction. Several cross-compartment correlations persisted following FDR adjustment, particularly for selected HCH isomers and 4,4'-DDE. CYP1A1 activity did not differ between groups. Among oxidative biomarkers, only urinary o,o'-dityrosine remained significantly lower in cancer patients after FDR correction. In adjusted genetic models, no polymorphism demonstrated a statistically robust association in the overall analysis; the GSTP1 estimate was elevated but imprecise.
conclusionDirect quantification of POPs in gastric tissue revealed selective accumulation patterns associated with stomach cancer. While systemic distribution and genetic variability may influence susceptibility, tissue-level POP differences represented the most consistent findings. Larger prospective studies are warranted to clarify temporal and mechanistic relationships.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.